These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19028629)

  • 1. In vitro release of fusidic acid and teicoplanin from cancellous bone allografts.
    Kanellakopoulou K; Sahinides T; Tsaganos T; Galanakis N; Giamarellou H; Giamarellos-Bourboulis EJ
    J Chemother; 2008 Oct; 20(5):645-7. PubMed ID: 19028629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro elution of moxifloxacin from cancellous bone allografts.
    Kanellakopoulou K; Sahinides T; Tsaganos T; Galanakis N; Giamarellou H; Giamarellos-Bourboulis EJ
    J Biomed Mater Res A; 2010 Jan; 92(1):52-5. PubMed ID: 19165791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis.
    Ersoz G; Oztuna V; Coskun B; Eskandari MM; Bayarslan C; Kaya A
    J Chemother; 2004 Feb; 16(1):51-5. PubMed ID: 15077999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan).
    Panagopoulos P; Tsaganos T; Plachouras D; Carrer DP; Papadopoulos A; Giamarellou H; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Dec; 32(6):485-7. PubMed ID: 18790611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancellous bone as an antibiotic carrier.
    Witsø E; Persen L; Løseth K; Benum P; Bergh K
    Acta Orthop Scand; 2000 Feb; 71(1):80-4. PubMed ID: 10743999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of cytokines in rats following the use of prophylactic agents in vascular graft infection.
    Gul M; Yasim A; Aral M
    Bratisl Lek Listy; 2010; 111(6):316-20. PubMed ID: 20635674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects.
    Yenice I; Caliş S; Atilla B; Kaş HS; Ozalp M; Ekizoğlu M; Bilgili H; Hincal AA
    J Microencapsul; 2003; 20(6):705-17. PubMed ID: 14594660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model.
    Zhang X; Jia W; Gu Y; Xiao W; Liu X; Wang D; Zhang C; Huang W; Rahaman MN; Day DE; Zhou N
    Biomaterials; 2010 Aug; 31(22):5865-74. PubMed ID: 20434766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-impregnated plaster of Paris beads. Trials with teicoplanin.
    Dacquet V; Varlet A; Tandogan RN; Tahon MM; Fournier L; Jehl F; Monteil H; Bascoulergue G
    Clin Orthop Relat Res; 1992 Sep; (282):241-9. PubMed ID: 1387599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of mechanical strength of teicoplanin and ciprofloxacin impregnated bone cement on Day 1 and Day 15.
    Gölge UH; Oztemur Z; Parlak M; Tezeren G; Oztürk H; Bulut O
    Acta Orthop Traumatol Turc; 2014; 48(3):333-8. PubMed ID: 24901926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis.
    Jia WT; Zhang X; Luo SH; Liu X; Huang WH; Rahaman MN; Day DE; Zhang CQ; Xie ZP; Wang JQ
    Acta Biomater; 2010 Mar; 6(3):812-9. PubMed ID: 19770078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC; Simon M
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanical strength of antibiotic-impregnated bone cement on Day 0 and Day 15: a biomechanical study with Surgical Simplex P and teicoplanin].
    Göğüş A; Akman S; Göksan SB; Bozdağ E
    Acta Orthop Traumatol Turc; 2002; 36(1):63-71. PubMed ID: 12510113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads.
    Wichelhaus TA; Dingeldein E; Rauschmann M; Kluge S; Dieterich R; Schäfer V; Brade V
    J Antimicrob Chemother; 2001 Jul; 48(1):117-9. PubMed ID: 11418521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusidic acid in dermatology: an updated review.
    Schöfer H; Simonsen L
    Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable implantable teicoplanin beads for the treatment of bone infections.
    Yenice I; Caliş S; Kaş H; Ozalp M; Ekizoğlu M; Hincal A
    Int J Pharm; 2002 Aug; 242(1-2):271-5. PubMed ID: 12176262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elution characteristics of teicoplanin-loaded biodegradable borate glass/chitosan composite.
    Jia WT; Zhang X; Zhang CQ; Liu X; Huang WH; Rahaman MN; Day DE
    Int J Pharm; 2010 Mar; 387(1-2):184-6. PubMed ID: 19995595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibiotics supplemented bone cement improved the masquelet's induced membrane in a rat femur critical size defect model.
    Ziroglu N; Koluman A; Kaleci B; Tanriverdi B; Tanriverdi G; Kural A; Bilgili MG
    Injury; 2023 Feb; 54(2):329-338. PubMed ID: 36334950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.